Karan Johar, Ram Kapoor, Kusha Kapila face Ozempic barbs: Why this appetite for hate when it comes to celebs and their bodies?  | Bollywood News

The Body-Shaming Cycle: Will Celebrity Criticism Ever End? The internet, once hailed as a bastion of free expression, has become a breeding ground for harsh criticism. Celebrity appearances, particularly weight changes, have become a constant source of online scrutiny. From social media comments to news headlines, the focus often shifts from talent and performance to … Read more

Do Medicare and Medicaid cover weight loss drugs?

The Future of Medicare Coverage for Anti-Obesity Drugs The debate over Medicare coverage for anti-obesity drugs like Wegovy and Zepbound is far from settled. With the recent decision by the Trump administration to decline a proposal from the Biden administration, millions of Americans affected by obesity are left in a state of uncertainty. However, future … Read more

The Right Angle with Sonal Kalra: Ozempic, Mounjaro or lifestyle change? The debate goes on

Exploring the Intersection of Health, Celebrity Influence, and Future Wellness Trends The Rising Popularity of Ozempic and Mounjaro The increasing fascination with medications like Ozempic and Mounjaro for weight management has caught the world’s eye. Originally intended for diabetes treatment, these drugs have found a celebrity following. Public figures, including Hollywood icons like Amy Schumer … Read more

Fat, skinny and skinny-fat: A weight-loss drug may not be the answer

The health/” title=”How to lose weight after 50? Dietician shares simple steps to shed pounds and stay …y | …”>Future of Weight Management: Beyond the Pill As society becomes increasingly conscious of health, the dialogue surrounding weight management has reached new heights, led in part by celebrities like Whoopi Goldberg, who advocates for awareness via … Read more

Eli Lilly launches its blockbuster weight loss drug Mounjaro in India

The Rise of Weight-Loss Pharmaceuticals in India The Indian pharmaceutical landscape is witnessing a significant transformation with the introduction of weight-loss drugs like Mounjaro by Eli Lilly & Co. This revolutionary drug, priced at ₹14,000 to ₹17,500 per month, is tailored for the Indian market, marking a competitive entry into the burgeoning sector of GLP-1 … Read more

Popular weight-loss drugs could shift the economy, create healthier workforce

The Economic Impact of Weight-Loss Drugs: A Future of Healthier Economies? As groundbreaking medications like Ozempic, Wegovy, and Mounjaro surge in popularity, experts speculate on a potential economic boom driven by healthier populations. Goldman Sachs forecasts a steady GDP increase if these drugs are adopted widely, with a potential 1% GDP boost by 2028 if … Read more

San Antonio doctor addresses concerns over GLP-1 medications

GLP-1 Medications: The Rising Stars in Weight Management The popularity of GLP-1 medications like Ozempic, Mounjaro, and Wegovy is surging due to their effective role in weight management, even beyond their initial diabetic applications. Understanding their mechanism and potential future trends can shed light on the evolving landscape of healthcare and wellness solutions. The Science … Read more